TG MONTGOMERY AS
Aksjeselskap (AS) · Oslo, Norway · LEI 549300Y4E8RC4YEPM866
LEI lapsed
Summary
TG MONTGOMERY AS is registered in Norway and entered in the “Register of Business Enterprises (Foretaksregisteret)” under number 988 462 624. Its legal form is Aksjeselskap (AS) – limited company (Norway). According to GLEIF, its ultimate parent is IMMUNOPHARMA AS (Norway), which is also its direct parent. That group has 1 subsidiary with LEIs in 1 country, 1 of them in Norway. The LEI was first issued on 7 Dec 2017 and the record was last updated on 9 Aug 2023. It has lapsed: renewal was due by 23 Nov 2022. AssetCensus found 3 data-quality notes for this entity (see below).
Written from GLEIF data using fixed, reviewed sentence templates.
Data-quality notes (AssetCensus analysis)
- The LEI has lapsed: it was due for renewal by 23 Nov 2022 and was not renewed, so GLEIF's data for this entity has not been re-verified since. A lapsed LEI does not mean the company has ceased to exist.
- The ultimate-parent link rests on accounts for the period ending 31 Dec 2021, more than 24 months before this data release. The group may have changed since.
- The ultimate-parent relationship record was not renewed; it was last updated on 9 Aug 2023.
Company details
| Legal form | Aksjeselskap (AS) limited company (Norway) |
|---|---|
| Register | Register of Business Enterprises (Foretaksregisteret) · Register website |
| Registration number | 988 462 624 |
| Registration authority | The Brønnøysund Register Centre |
| Jurisdiction | Norway |
| Registered address | Lilleakerveien 2B, 0283 Oslo, Norway |
| Category | company or other legal entity |
| Status | active |
| LEI | 549300Y4E8RC4YEPM866 |
| LEI status | lapsed |
| LEI first issued | 7 Dec 2017 |
| LEI record last updated | 9 Aug 2023 |
| Next LEI renewal | 23 Nov 2022 |
| Corroboration of the LEI record | fully corroborated |
Group membership
TG MONTGOMERY AS this entity
Relationship to the parent
| Direct parent | Ultimate parent | |
|---|---|---|
| Parent | IMMUNOPHARMA AS | IMMUNOPHARMA AS |
| Accounting period | 1 Jan 2021 to 31 Dec 2021 | 1 Jan 2021 to 31 Dec 2021 |
| Evidence | supporting documents | supporting documents |
| Corroboration | partly corroborated | partly corroborated |
| Relationship start | 23 Nov 2021 | 23 Nov 2021 |
| Recorded at GLEIF since | 7 Dec 2017 | 7 Dec 2017 |
| Last updated | 9 Aug 2023 | 9 Aug 2023 |
| Record status | not renewed | not renewed |